Results of a Screening Program for Diagnosis of Amyloid Cardiomyopathy Among Patients with Left Ventricular Hypertrophy: PAPCAT Cardiac Amyloidosis Turkiye Survey
| dc.authorwosid | Eraslan, Selda/Abh-1463-2022 | |
| dc.authorwosid | Tufekcioglu, Omac/Aae-4660-2020 | |
| dc.authorwosid | Colak, Ayse/Jkj-2387-2023 | |
| dc.authorwosid | Altay, Hakan/Aae-1392-2021 | |
| dc.authorwosid | Zorkun, Cafer/Q-1247-2019 | |
| dc.authorwosid | Güler, Arda/Hjy-2884-2023 | |
| dc.authorwosid | Akaslan, Dursun/Aaa-6795-2020 | |
| dc.contributor.author | Ozpelit, Ebru | |
| dc.contributor.author | Cavusoglu, Yuksel | |
| dc.contributor.author | Guler, Gamze Babur | |
| dc.contributor.author | Unlu, Serkan | |
| dc.contributor.author | Yildirimturk, Ozlem | |
| dc.contributor.author | Yilmaz, Dilek Cicek | |
| dc.contributor.author | Degertekin, Muzaffer | |
| dc.date.accessioned | 2025-11-30T19:13:56Z | |
| dc.date.available | 2025-11-30T19:13:56Z | |
| dc.date.issued | 2025 | |
| dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
| dc.department-temp | [Ozpelit, Ebru; Colak, Ayse] Dokuz Eylul Univ, Fac Med, Dept Cardiol, Izmir, Turkiye; [Cavusoglu, Yuksel; Murat, Selda] Eskisehir Osmangazi Univ, Fac Med, Dept Cardiol, Eskisehir, Turkiye; [Guler, Gamze Babur; Guler, Arda] Mehmet Akif Ersoy Thorac & Cardiovasc Surg Trainin, Dept Cardiol, Istanbul, Turkiye; [Unlu, Serkan] Gazi Univ, Dept Cardiol, Fac Med, Ankara, Turkiye; [Yildirimturk, Ozlem] Dr Siyami Ersek Thorac & Cardiovasc Surg Training, Dept Cardiol, Istanbul, Turkiye; [Yilmaz, Dilek Cicek] Mersin Univ, Dept Cardiol, Fac Med, Mersin, Turkiye; [Orem, Cihan; Sahin, Mursel] Karadeniz Tech Univ, Dept Cardiol, Farabi Hosp, Trabzon, Turkiye; [Basarici, Ibrahim; Kaplan, Elmas] Akdeniz Univ, Fac Med, Dept Cardiol, Antalya, Turkiye; [Tufekcioglu, Omac] Ankara Bilkent City Hosp, Dept Cardiol, Ankara, Turkiye; [Tokgozoglu, Lale; Karakulak, Ugur Nadir] Hacettepe Univ, Fac Med, Dept Cardiol, Ankara, Turkiye; [Dincer, Irem] Ankara Univ, Dept Cardiol, Fac Med, Ankara, Turkiye; [Kaya, Gamze Capa] Dokuz Eylul Univ, Fac Med, Dept Nucl Med, Izmir, Turkiye; [Sivrioz, Ilknur Ak] Eskisehir Osmangazi Univ, Fac Med, Dept Nucl Med, Eskisehir, Turkiye; [Akaslan, Dursun; Sunbul, Murat] Marmara Univ, Fac Med, Dept Cardiol, Istanbul, Turkiye; [Cabbar, Ayce Turer; Degertekin, Muzaffer] Yeditepe Univ, Fac Med, Dept Cardiol, Istanbul, Turkiye; [Kaya, Yuksel] Van Yuzuncu Yil Univ, Fac Med, Dept Cardiol, Van, Turkiye; [Zorkun, Cafer Sadik] Istanbul Univ Istanbul, Med Fac, Dept Cardiol, Istanbul, Turkiye; [Agca, Fahriye Vatansever] Univ Hlth Sci Bursa Yuksek Ihtisas Training & Res, Dept Cardiol, Bursa, Turkiye; [Ikitimur, Baris] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Cardiol, Istanbul, Turkiye; [Onbasili, Alper] Aydin Adnan Menderes Univ, Fac Med, Dept Cardiol, Aydin, Turkiye; [Kilicgedik, Alev] Basaksehir Cam & Sakura City Hosp, Dept Cardiol, Turkiye, Istanbul, Turkiye; [Altay, Hakan] Baskent Univ, Dept Cardiol, Istanbul Hosp, Istanbul, Turkiye; [Buyukoner, Elif Eroglu] Acibadem Mehmet Ali Aydinlar Univ, Dept Cardiol, Fac Med, Istanbul, Turkiye | en_US |
| dc.description.abstract | Background: Cardiac amyloidosis (CA) is an increasingly recognized disease. Several recent advanced imaging techniques and parameters have been introduced into the diagnosis of CA. However, the first step in using those techniques is clinical suspicion. Left ventricular hypertrophy (LVH) is the main entity in rising the suspicion of CA in routine echocardiography, although it is not a diagnosisfor CA. The aim of this study isto investigate the prevalence of CA and its subtypes and predictive value of clinical and echocardiographic red flags of CA among consecutive adult patients with LVH identified during routine echocardiographic examination in 25 tertiary institutions in T & uuml;rkiye. Methods: This was a prospective observational multicenter, national registration study. Patients with LVH (interventricular septum thickness >= 13 mm or >15 mm in those with hypertension) were screened for CA stepwise. The first step was a clinical questionnaire for the red flags of CA. Those having >= 2 red flags were further analyzed by detailed echocardiography, blood tests, Tc-pyrophosphate (PYP) bone scintigraphy, and histopathological examination if needed. Parameters associated with CA were evaluated via univariate and multivariate analyses. Wild-type transthyretin (wTTR) vs. mutant-type TTR (mTTR), CA discriminators were also evaluated in the same manner. Results: A total of 420 patients meeting these criteria were included in the study. With a standardized algorithmic approach, 27.1% (114) of patients received a CA diagnosis. Among these patients with CA, 50.8% (58) were diagnosed with immunoglobulin free chain (AL) CA, 38.6% (44) with wTTR CA, and 7% (8) with mTTR CA. Leftventricular apical sparing pattern and restrictive type LV filling on echocardiography, low QRS voltage on ECG, bilateral carpal tunnel syndrome, low blood pressure, right ventricular diameter, and an increased basal heart rate (HR) were independent predictorsfor CA diagnosis. When it comesto diagnosis of wTTR CA; advanced age (age >75), lowertroponin values, absence of pericardial effusion and absence of proteinuria were the independent predictors. Conclusion: Cardiac amyloidosis is highly prevalent in a patient population with LVH and >2 red flagswho underwent a standardized algorithmic approach, in which apical sparing, restrictive filling pattern, low QRS voltage, carpal tunnel syndrome, low blood pressure, and increased HR are the highly suggestive signs of CA. Among this pool of newly diagnosed CA patients in T & uuml;rkiye, AL-CA constituted 50.8%, wTTR CA 38.6%, and mTTR CA 7%, emphasizing that approximately 1 in 2 patients diagnosed with CA may have TTR CA. | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded | |
| dc.identifier.doi | 10.14744/AnatolJCardiol.2025.4942 | |
| dc.identifier.endpage | 581 | en_US |
| dc.identifier.issn | 2149-2263 | |
| dc.identifier.issn | 2149-2271 | |
| dc.identifier.issue | 10 | en_US |
| dc.identifier.pmid | 40808528 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 571 | en_US |
| dc.identifier.uri | https://doi.org/10.14744/AnatolJCardiol.2025.4942 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14720/28990 | |
| dc.identifier.volume | 29 | en_US |
| dc.identifier.wos | WOS:001592862400009 | |
| dc.identifier.wosquality | Q3 | |
| dc.language.iso | en | en_US |
| dc.publisher | Kare Publ | en_US |
| dc.relation.ispartof | Anatolian Journal of Cardiology | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Amyloidosis | en_US |
| dc.subject | Cardiac Amyloidosis | en_US |
| dc.subject | Left Ventricular Hypertrophy | en_US |
| dc.subject | Transthyretin Cardiac Amyloidosis | en_US |
| dc.title | Results of a Screening Program for Diagnosis of Amyloid Cardiomyopathy Among Patients with Left Ventricular Hypertrophy: PAPCAT Cardiac Amyloidosis Turkiye Survey | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |